Communiqués Actavia Life Sciences, Inc.

Actions

RASP

US7538881068

Marché Fermé - OTC Markets Autres places de cotation 20:18:48 21/06/2024			Varia. 5j.	Varia. 1 janv.
0,0016 ^USD	-82,22 %		0,00 %	-79,22 %

20/05	Actavia Life Sciences, Inc. annonce ses résultats pour le deuxième trimestre et le semestre clos le 31 mars 2024	CI
16/02	Actavia Life Sciences, Inc. annonce ses résultats pour le premier trimestre clos le 31 décembre 2023	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Actavia Life Sciences : Change in Certifying Accountants - Form 8-K	10/04	PU
RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	02/03/23	AQ
RASNA THERAPEUTICS INC. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	09/02/23	AQ
Rasna Therapeutics : Certificate of Incorporation/Bylaws - Form 8-K	24/01/23	PU
RASNA THERAPEUTICS INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	23/01/23	AQ
RASNA THERAPEUTICS INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	20/12/22	AQ
RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22/08/22	AQ
RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	21/06/22	AQ
RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	16/06/22	AQ
Rasna Therapeutics : Amendment to Annual Report (Form 10-K/A)	10/06/22	PU
RASNA THERAPEUTICS INC. - 10-K/A - MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	10/06/22	AQ
Rasna Therapeutics : Unregistered Sales of Equity Securities - Form 8-K	24/05/22	PU
RASNA THERAPEUTICS INC. : Unregistered Sale of Equity Securities (form 8-K)	24/05/22	AQ
RASNA THERAPEUTICS INC. : Unregistered Sale of Equity Securities (form 8-K)	19/05/22	AQ
RASNA THERAPEUTICS INC. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)	09/05/22	AQ
RASNA THERAPEUTICS INC. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	01/03/22	AQ
RASNA THERAPEUTICS INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	30/11/21	AQ
RASNA THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	16/08/21	AQ
RASNA THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	02/06/21	AQ
RASNA THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	05/04/21	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Actavia Life Sciences, Inc.

Actions

RASP

US7538881068

Communiqués

Filtres